Shop3D.ca Blackout - Black Friday Deals Start Now

Lulzbot Bio (Announced)

Available Stock:
Loading...

Lulzbot Bio - Bioprinting 3D Printer

FluidForm’s novel platform of Freeform Reversible Embedding of Suspended Hydrogels (FRESH) 3D printing enables fabrication of soft, biological scaffolds for applications in tissue engineering and regenerative medicine.

Technical Specs
Material Safety Data Sheet | Technical Data Sheet
  • Print Technology: Fluid Deposition Fabrication
  • Print Head: Syringe Pump Extruder
  • Maximum Print Area: 160mm x 160mm x 89mm1 (6.30in x 6.30in x 3.5in1 )
  • Minimum Layer Resolution: 50 µm2
  • Minimum Positive Feature Size: 80 µm3
  • Calculated XYZ Positional Resolution: 10, 10, 5 µm
  • Recommended Operating Temperature: From 5°C to 40°C (41°F to 104°F)
  • Operating Footprint: 45.7cm x 40.6cm (18in x 16in)
  • Connectivity: USB Serial and SD Card
  • Print Surface: Heated Borosilicate Glass
  • Maximum Print Surface Temperature: Up to 120°C (248°F)
  • Print Surface Heat Up Time: 23°C to 60°C (73°F to 140°F) in 97 seconds
  • Interface: Glove-Friendly 4.5” Touch-Screen
Electrical and Software
  • Power Requirements: 100VAC-240VAC, 50Hz-60Hz, 3.2A max
  • Output: 24VDC
  • Power Supply: IEC cord, C13 to region-specific connector
  • Operating System Compatibility: GNU/Linux, Mac, Windows
  • Recommended Software: Cura LulzBot Edition (Latest Version)
  • Firmware: Marlin
  • Supported File Types: .stl, .obj, .g, .gcode, .x3d, .3mf
3D Bioprinting: Revolutionizing Key Industries.
3D biofabrication technology is revolutionizing applications across a wide spectrum of industries, including pharmaceuticals, regenerative medicine, drug screening, food and other animal products, cell-based biosensors, and testing of cosmetics and other health care goods. Within the next decade, major pharmaceutical companies will  be able to replace some animal testing and non-physiological 2D cell culture systems with clinically-relevant 3D bioprinted human tissues.
“Combining proven expertise in professional 3D printers and hardware with 3D biofabrication technology is going to be an absolute game-changer, the market for 3D bioprinters and 3D bioprinted tissues is estimated to grow to $1.9 billion by 2028.” - Aleph Objects CEO and President Grant Flaharty.

Our Expert Staff Are Here to Help

We are available to assist you in finding the right fit for your project while answering your technical questions.
  • Toronto
    905-501-8558
    10am-6pm EST, Monday-Friday
  • Vancouver
    604-336-9393
    10am-6pm PST, Monday-Friday
Speak with our Applications Engineer to find efficiencies and determine your ROI - Book a Technical Consultation

Related Items